Found: 11
Select item for more details and to access through your institution.
Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 534, doi. 10.1002/cpdd.1379
- By:
- Publication type:
- Article
Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 326, doi. 10.1002/cpdd.1388
- By:
- Publication type:
- Article
Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 553, doi. 10.1002/cpdd.1255
- By:
- Publication type:
- Article
Steady-state trough concentrations and their relationship to selected demographic and clinical response measures in etrasimod-treated patients with moderately-to-severely active ulcerative colitis.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S143, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Grapefruit juice and orange juice effects on the bioavailability of nifedipine in the rat.
- Published in:
- Biopharmaceutics & Drug Disposition, 1998, v. 19, n. 3, p. 175, doi. 10.1002/(SICI)1099-081X(199804)19:3<175::AID-BDD85>3.0.CO;2-7
- By:
- Publication type:
- Article
EXTRAHEPATIC FIRST-PASS METABOLISM OF NIFEDIPINE IN THE RAT.
- Published in:
- Biopharmaceutics & Drug Disposition, 1997, v. 18, n. 6, p. 509, doi. 10.1002/(SICI)1099-081X(199708)18:6<509::AID-BDD38>3.0.CO;2-5
- By:
- Publication type:
- Article
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-α delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 1, p. 32, doi. 10.1215/S1152851703000353
- By:
- Publication type:
- Article
Changes in mipomersen dosing regimen provide similar exposure with improved tolerability in randomized placebo-controlled study of healthy volunteers.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Changes in Mipomersen Dosing Regimen Provide Similar Exposure With Improved Tolerability in Randomized Placebo-Controlled Study of Healthy Volunteers.
- Published in:
- Journal of the American Heart Association, 2014, v. 3, n. 1, p. 1, doi. 10.1161/JAHA.113.000560
- By:
- Publication type:
- Article
Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 2, p. 1, doi. 10.1177/2045894020922814
- By:
- Publication type:
- Article